The Technical Analyst
Direxion Daily [PILL]
Exchange: NYSE Sector: Miscellaneous
Direxion Daily Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $6.88
America/New_York / 9 mai 2024 @ 11:48
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 12.59 mill |
| EPS: | 0.546 |
| P/E: | 12.60 |
| Earnings Date: | N/A |
| SharesOutstanding: | 1.830 mill |
| Avg Daily Volume: | 0.0867 mill |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 12.60 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.93x |
| Company: PE 12.60 | industry: PE 13.52 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 6.54 - 7.20 ( +/- 4.82%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2006-12-13 | Falk Michael | Sell | 1 040 106 | Common Stock |
| 2006-12-13 | Falk Michael | Buy | 67 233 | Common Stock |
| 2006-04-16 | Falk Michael | Buy | 3 333 | Option to Purchase Common Stock |
| 2006-08-28 | Mcguire James | Buy | 0 | |
| 2005-09-06 | Mcguire James | Sell | 0 | Common Stock |
| INSIDER POWER |
|---|
| 0.00 |
| Last 53 transactions |
| Buy: 3 204 364 | Sell: 2 628 070 |
Forecast:
13:17 - $6.85
Live Trading Signals (every 1 min)
Forecast
1: 11:47 - $6.87
Forecast 2: 12:37 - $6.87
Forecast 3: 13:17 - $6.85
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $6.88 (0.00% ) |
| Volume | 0.0367 mill |
| Avg. Vol. | 0.0867 mill |
| % of Avg. Vol | 42.39 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PILL
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
PILL
The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.
Latest News
2024-02-21 14:30:54 - ETF Trends
Top Performing Leveraged/Inverse ETFs: 02/18/2024
These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
2024-02-20 13:05:23 - Zacks Investment Research
5 Best Leveraged ETFs of First Half of Q1
We highlight a bunch of the best-performing leveraged equity ETFs from different corners of the market that are leaders in their segments in the first half of Q1.
2023-12-26 09:01:05 - Zacks Investment Research
5 Best Inverse/Leveraged ETFs of Last Week
The optimism surrounding the likely Fed rate cuts in 2024 aided the rally in the market last week, barring some occasional dips.
2023-01-11 18:09:00 - Seeking Alpha
Can Health Care Stocks Outperform Again In 2023?
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
2022-09-13 19:13:39 - ETF Trends
Top Performing Leveraged/Inverse ETFs: 09/11/2022
Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
2022-06-29 14:29:34 - ETF Trends
Top Performing Leveraged/Inverse ETFs: 06/26/2022
Top Performing Levered/Inverse ETFs Last Week These were last week's top-performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
2022-03-28 14:32:00 - Seeking Alpha
Pharma In Transition: Context And Opportunities
The pending separation of consumer care businesses by pharmaceutical companies is understandable and may offer investment opportunities.
2021-11-08 09:14:06 - Zacks Investment Research
Best Leveraged ETF Areas of Last Week
Wall Street was at the record high last week due to upbeat corporate earnings, strong jobs data and Pfizer's pill study.
2021-08-16 18:25:47 - ETF Trends
3 ETFs to Access a Changing Pharmaceutical Industry
A changing pharmaceutical industry is setting up a few trades in the leveraged fund space, specifically for ETFs from Direxion Investments. One of the catalysts for change, especially within the past year is the incorporation of more e-commerce channels for distribution.
2021-07-26 14:35:05 - Zacks Investment Research
5 Best Leveraged ETFs of Last Week
Wall Street was overall upbeat last week. Though concerns about the spread of the Delta Variant of coronavirus worried investors, low rates boosted the demand for stock investments.